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NGF Signaling from Clathrin-Coated Vesicles:
Evidence that Signaling Endosomes Serve
as a Platform for the Ras-MAPK Pathway
and others (Ehlers et al., 1995; Grimes et al., 1996; Bhat-
tacharyya et al., 1997; Grimes et al., 1997; Riccio et al.,
1997; Senger and Campenot, 1997; Tsui-Pierchala and
Ginty, 1999; Watson et al., 1999; Zhang et al., 2000;
Kuruvilla et al., 2000) have tested the third model, i.e.,
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that the NGF signal is transmitted via endocytosis ofMSLS P211
complexes containing NGF bound to its activated recep-Stanford, California 94305
tor tyrosine kinase (RTK) TrkA, followed by retrograde
transport of the “signaling endosomes” thus formed.
In vitro and in vivo data support this hypothesis. TrkASummary
endocytosis is enhanced by NGF, and crude endosomal
fractions from NGF-treated PC12 cells contain NGF andThe target-derived neurotrophic factor “nerve growth
activated TrkA (Grimes et al., 1996, 1997). Furthermore,factor” (NGF) signals through TrkA to promote the
using cultures in which sympathetic neuron cell bodiessurvival, differentiation, and maintenance of neurons.
and their processes were compartmentalized, NGFHow the NGF signal in axon terminals is conveyed to
treatment of distal processes was followed by retro-the cell body is unknown. The “signaling endosome
grade transport of a complex containing NGF and acti-hypothesis” envisions that NGF-TrkA complexes are
vated TrkA (Tsui-Pierchala and Ginty, 1999; Kuruvilla etinternalized at the axon terminal and retrogradely
al., 2000). Possibly in response to the retrograde deliverytransported to the cell body. Following NGF treatment,
of this complex, there was increased phosphorylationwe found that clathrin-coated vesicles contained NGF
within cell bodies of a number of proteins (Senger andbound to TrkA together with activated signaling pro-
Campenot, 1997), including CREB (Riccio et al., 1997).teins of the Ras-MAP kinase pathway. Evidence that
Very similar findings have been documented for BDNFthese vesicles could signal was their ability in vitro to
acting through TrkB in compartmentalized cultures ofactivate Elk, a downstream target of Erk1/2. Our re-
DRG neurons (Watson et al., 1999). Finally, in vivo stud-sults point to the existence of a population of signaling
ies have shown that activated Trk receptors, as well asendosomes derived from clathrin-coated membranes
Erk and several downstream effectors of the Erk cas-in NGF-treated cells.
cade, are retrogradely transported in sciatic nerve (Ehl-
ers et al., 1995; Johanson et al., 1995; BhattacharyyaIntroduction
et al., 1997). Taken together, the evidence favors the
existence of signaling endosomes. However, no well-Targets of neuronal innervation play a vital role in regu-
defined preparation of endosomes has been isolatedlating the survival and differentiation of innervating neu-
and shown to propagate the neurotrophin signal(s).
rotrophin-responsive neurons. It is well established that
Stimulated by observations that suggested a link
NGF and other neurotrophic factors are produced and
among NGF signaling, clathrin-coated membrane for-
released in target tissues to activate receptors on the mation, and TrkA trafficking (Grimes et al., 1996, 1997;
presynaptic elements of innervating neurons, thereby Beattie et al., 2000), we asked whether NGF treatment
signaling to regulate the survival and differentiation of induced the formation of clathrin-coated vesicles (CCVs)
these neurons (Casaccia-Bonnefil et al., 1999, Sofroniew that carry the NGF signal. Herein, we show that NGF
et al., 2001). An unresolved issue is the mechanism via increased the association of clathrin with membranes
which signals generated by neurotrophic factors are in both PC12 cells and dorsal root ganglia (DRG) neurons
communicated from axon terminals to cell bodies. Three and that NGF induced the formation of complexes con-
mechanisms have been proposed (Hendry and Crouch, taining activated TrkA, the clathrin heavy chain (CHC),
1993; Campenot, 1994). (1) The neurotrophin is internal- and the plasma membrane-specific clathrin adaptor
ized and transported from the axon tip to the cell body, protein, AP2. Linking the formation of this complex to
whereupon it binds to receptors to initiate signaling cas- endocytosis via clathrin-coated membranes, CCVs iso-
cades. (2) The neurotrophin activates presynaptic re- lated from NGF-treated cells contained NGF bound to
ceptors, which initiate signaling cascades that reach the activated TrkA. Remarkably, we discovered that CCVs
cell body in a wavelike fashion. (3) The neurotrophin contained signaling proteins that participate in the Ras-
binds and activates presynaptic receptors that induce MAP kinase (Ras-MAPK) pathway and that the amounts
internalization of ligand-receptor complexes into endo- of several of these proteins and of their activated forms
somes that are retrogradely trafficked to the cell body, were significantly increased by NGF treatment. Showing
where they initiate local signal transduction cascades. that NGF-induced CCVs can signal, in an in vitro kinase
The available evidence has neither conclusively proven assay they conveyed the NGF signal to Elk, a down-
nor discounted the existence of any of the models. In- stream target of activated Erk. Finally, we found evi-
deed, the possibility exists that all may play a role. We dence that clathrin-mediated trafficking appears to play
a critical role in the flow of information from TrkA recep-
tor activation to the engagement of the Ras-MAPK path-1 Correspondence: howe.charles@mayo.edu
way. Our findings indicate that NGF does signal from2 Present address: Department of Neurology, Mayo Clinic, Roches-
ter, Minnesota 55905. endosomes, and they suggest that CCVs are one source
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of the signaling endosomes produced in response to
NGF treatment.
Results
NGF-Induced Recruitment of Clathrin to Surface
and Intracellular Membranes
To determine whether clathrin-coated membranes con-
tribute to the endocytosis of activated TrkA, we charac-
terized clathrin recruitment to membranes in response
to NGF. By confocal microscopy, CHC staining in un-
treated PC12 cells was seen in small puncta distributed
diffusely throughout cells, with most staining in the cyto-
plasm (Figure 1A). In contrast, in cells treated with NGF
for 2 min, there was a robust redistribution of CHC immu-
nostaining, with many large, bright puncta located near
the plasma membrane (Figure 1C). Recruitment was
transient in that no increase near surface membranes
was evident after 15 min of NGF treatment (data not
shown). NGF also induced redistribution of clathrin in
DRG neurons (compare Figures 1B and 1D). These find-
ings are evidence that NGF elicited a robust redistribu-
tion of clathrin to plasma membrane.
We quantitatively examined the NGF-induced in-
crease in membrane-associated CHC. PC12 cells were
homogenized using a method that gently shears cells
while favoring the continued association of clathrin with
membranes. From the homogenate, membranes were
fractionated using two different protocols (see Experi-
mental Procedures). In the first, we isolated a fraction
enriched in plasma membrane and depleted of cytosol.
In the second, we isolated internal membranes. NGF
treatment for 2 min increased the amount of membrane-
associated CHC in the plasma membrane-enriched
preparation by 58% (5.6%; n  7; p  0.001 versus
untreated) (Figure 1E) and in the internal membrane frac-
tion by 145% (10.1%; n  3; p  0.001 versus un-
treated) (Figure 1F). These findings are evidence that
NGF elicits the redistribution of clathrin to both surface
and internal membranes.
Next, we examined the effect of NGF on clathrin asso-
ciated with membranes in DRG neurons. The whole cell
membrane (WCM) fraction from treated and untreated
Figure 1. NGF-Induced Redistribution of Clathrin to Membranes cells was lysed and immunoprecipitated for CHC. NGF
(A–D) PC12 cells or DRG neurons were treated with NGF (2 nM) at induced a 2-fold increase (n  2) in CHC associated
37C for 2 min or left untreated. Cells were immunostained with with WCM in DRG neurons (Figure 1G). Taken together
X.22, an Ab to the clathrin heavy chain (CHC).
with the results of CHC immunostaining (Figures 1B and(A) In untreated PC12 cells, CHC immmunostaining was diffuse and
1D), this finding is evidence that NGF enhances clathrinlocalized primarily in the cytoplasm.
association with surface membranes in neurons.(B) Likewise, in untreated DRG neurons the CHC immunostaining
was diffuse and cytoplasmic. Finally, we examined the effect of NGF treatment on
(C) Following NGF treatment, bright punctate staining was present the association of clathrin with membranes derived from
at the periphery of PC12 cells. CNS neurons. For this experiment, synaptosomes were
(D) NGF treatment also resulted in redistribution of CHC immuno-
isolated from adult rat hippocampus. NGF induced anstaining to the cell surface of DRG neurons. Shown are representa-
8-fold (n  2) increase in the association of CHC withtive results from several hundred cells for each condition. The scale
synaptic terminal membranes (Figure 1H). These resultsbar for (A) and (C) is 5 m; for (B) and (D), it is 5 m.
(E and F) PC12 cells were treated for 2 min with NGF (2 nM) at 37C extend earlier findings (Beattie et al., 2000) and suggest
or left untreated.
(E) NGF treatment increased by 58% the amount of CHC in a fraction
enriched in plasma membrane.
(H) Likewise, rat hippocampal synaptosomes were either treated for(F) NGF treatment induced a 145% increase in CHC in a fraction
enriched in internal membranes. 2 min at 37C with NGF (2 nM) or left untreated. NGF induced an 8-fold
(n 2) increase in the association of CHC with the WCM fraction. The(G) DRG neurons were treated with NGF (2 nM) for 2 min at 37C or
left untreated. NGF elicited approximately a 2-fold (n  2) increase bottom panel in (H) shows that TrkA activation within synaptosomes
correlated with CHC redistribution.in the amount of CHC associated with the WCM fraction.
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membranes observed by immunostaining, the amount of
CHC in the immunoprecipitates returned to baseline by
15 min (96% of untreated; p  0.23) (Figure 2B).
To determine whether activated TrkA receptors were
present in NGF-induced complexes, we carried out im-
munoprecipitations with an antibody to tyrosine phos-
phorylated TrkA (Figure 2C). As in the total TrkA immuno-
precipitates, we found CHC and AP2 in a complex with
activated TrkA and showed that the amount increased
markedly following NGF treatment. The association with
CHC peaked at 2 min and returned to baseline levels
by 15 min. These findings are consistent with the pres-
ence of activated TrkA in clathrin-coated membranes
of NGF-treated cells. In that NGF did not induce redistri-
bution of clathrin in cells expressing kinase-defective
TrkA (Beattie et al., 2000), our findings suggest that TrkA
activation was responsible for the recruitment of CHC
and AP2 to TrkA in NGF-treated cells. We conclude that
NGF signaling results in the formation of complexes in
which activated TrkA is present together with molecules
that mediate endocytosis through the clathrin pathway.
NGF Was Internalized in Part through a Clathrin-
Mediated Pathway in PC12 Cells and Neurons
To test the prediction that complexes containing NGF
bound to activated TrkA are internalized via the clathrin
pathway, we asked whether 125I-NGF internalizationFigure 2. NGF Induced the Formation of Complexes Containing Ac-
would be affected by several inhibitors of clathrin-medi-tivated TrkA, CHC, and AP2
ated endocytosis: potassium depletion (Larkin et al.,PC12 cells were treated at 37C with NGF (2 nM) for the times
1983), monodansylcadaverine (MDC) (Davies et al.,indicated or were left untreated (0).
(A) An anti-TrkA antibody was used to immunoprecipitate the lysates 1984), and chlorpromazine (CPZ) (Sofer and Futerman
from an equal numbers of cells, and the blots were probed for 1995). We defined internalized NGF as that which re-
CHC (top), phospho-tyrosine (second from top), TrkA (second from mained associated with cells after stripping (see Experi-
bottom), or AP2 (bottom). NGF treatment resulted in TrkA activation
mental Procedures). Hypotonic shock followed by po-and increased association of CHC and AP2 with TrkA.
tassium depletion (K) or preincubation with either 100(B) Quantification of the amount of CHC observed in TrkA immunopre-
M CPZ or 50 M MDC blunted internalization of NGFcipitates (n  6 for all experiments; two asterisks indicate p  0.001).
(C) Cell lysates were immunoprecipitated with an antibody directed (Figure 3A). At 2 min, there was a statistically significant
against tyrosine phosphorylated TrkA (p-Y490). The Western blot of decrease in internalization with K (p  0.047), MDC
the immunoprecipitates was probed for CHC, phospho-tyrosine, or (p  0.0075), and CPZ (p  0.025). Likewise, following
AP2. There was a robust increase in complexes containing activated
5 min of 125I-NGF exposure, PC12 cells internalized sig-TrkA, CHC, and AP2 that peaked at 2 min. The result is representative
nificantly less NGF with K (p  0.0003), MDC (p of three independent experiments.
0.00054), and CPZ (p 0.0041). Furthermore, while NGF
internalization increased significantly between 2 and 5
min in the absence of inhibitors (p  0.00068 2 versusthat NGF acts at the level of cell bodies and synaptic
terminals to redistribute clathrin to the membranes of 5 min), there was no significant difference in the amount
of 125I-NGF internalized between 2 and 5 min under con-CNS neurons.
ditions of K or in the presence of MDC or CPZ (p 
0.73 2 versus 5 min K; p  0.77 2 versus 5 min MDC;TrkA Was Found in Complexes with AP2
and CHC Following NGF Treatment p  0.99 2 versus 5 min CPZ). Moreover, there was no
significant difference in the amount of 125I-NGF internal-The recruitment of clathrin to membranes that followed
NGF treatment raised the possibility that activated TrkA ized using any of the three inhibitors (at 2 min: p 0.43K
versus MDC, p 0.27K versus CPZ, and p 0.43 MDCwould be found in complex with CHC and with the
clathrin adaptor protein AP2. To test this prediction, versus CPZ; at 5 min: p  0.12 K versus MDC, p 
0.053 K versus CPZ, and p  0.62 MDC versus CPZ).NGF-treated PC12 cell lysates were immunoprecipitated
with an antibody to TrkA prior to immunoblotting for CHC, Importantly, at the concentrations used, neither MDC
(see Figure 7E) nor CPZ orK decreased TrkA activationAP2, phosphotyrosine, or TrkA. NGF treatment induced
a large increase in tyrosine-phosphorylated TrkA that in response to NGF treatment (data not shown).
The effect of the inhibitors was tested further in experi-peaked at 2 min (Figure 2A). The increase in activated
TrkA was associated with increases in both CHC and ments in which binding of NGF (2 nM) was carried out
for 1 hr at 4C to inhibit normal membrane-traffickingAP2. Significant increases in CHC were detected at 1
min (49%; p  0.001 versus untreated), at 2 min (75%; events. In the absence of inhibitors, there was a 49%
(6%; n  7; p  0.00001 versus unwarmed) increasep  0.001), and at 5 min (40%; p  0.001) (Figure 2B).
Consistent with the transient recruitment of clathrin to in NGF internalization after warming for 5 min at 37C.
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Figure 3. NGF Internalization and Ultrastruc-
tural and Biochemical Characterization of a
Fraction Enriched in CCVs
(A) Inhibitors of clathrin-mediated endocyto-
sis suppressed 125I-NGF internalization. PC12
cells were subjected to hypotonic shock and
potassium depletion (K) or incubated with
either 100 M chlorpromazine (CPZ), 50 M
monodansylcadaverine (MDC), or no additive
(none) for 15 min at 37C. In the continued
presence of the inhibitors, cells were incu-
bated with 125I-NGF (2 nM) for the times indi-
cated. Values shown are expressed as pg of
NGF internalized per g of protein (n  3
for all conditions; asterisk indicates p  0.05
versus no inhibitor, two asterisks indicate p
0.001 versus no inhibitor).
(B) Using identical treatment conditions, NGF
internalization was also inhibited in DRG neu-
rons following potassium depletion, MDC, or
CPZ (n  3 for all conditions; two asterisks
indicate p  0.001 versus no inhibitor).
(C) Electron microscopic analysis of the CCV
fraction showing typical CCV profiles. The
scale bar in the upper micrograph is 65 nm;
the scale bar at the bottom of all three micro-
graphs is 65 nm and refers to the two micro-
graphs of individual CCVs shown.
(D and E) Biochemical characterization of the
CCV fraction.
(D) Comparison of the relative levels of CHC,
AP2, EEA1, rab5, and nucleoporin in the CCV
fraction versus in an equivalent amount of
protein from WCL.
(E) Biotinylated transferrin accumulated in the
CCV fraction of PC12 cells.
In contrast, there was no increase in NGF internalization nm in diameter and that had the structure characteristic
of CCVs (Figure 3C). Fragmented CCVs and other smallin the presence of either MDC (6%  4%; n  3; p 
0.68 versus unwarmed) or CPZ (0%  1%; n  3; p  membrane fragments were also present at low levels.
Biochemical analysis showed that the CCV fraction was0.89). We conclude that internalization of NGF in PC12
cells is mediated in part by the clathrin pathway. enriched 71.4-fold in CHC (n  3; p  0.00011), as com-
We observed that NGF internalization in DRG neurons pared to an equivalent amount of protein from whole
was largely dependent upon endocytosis through the cell lysates (WCL) (Figure 3D). A similar enrichment was
clathrin pathway (Figure 3B). Using the same conditions observed for AP2 in the CCV fraction (Figure 3D). We
as Figure 3A, we measured the amount of NGF internal- found that both CCVs and the WCL contained rab5, a
ized during 15 min. As with PC12 cells, there was a signifi- GTPase that is associated with endocytic vesicles (Fig-
cant decrease in NGF internalization when clathrin-medi- ure 3D). Notably, Rab5 was enriched 17.7-fold (1.1-fold;
ated membrane trafficking was inhibited. Markedly less n  2; p  0.03) in CCVs relative to the WCL. This finding
NGF was internalized with K (p  0.00021), MDC (p  is consistent with the role rab5 plays in the biogenesis
0.00027), or CPZ (p  0.00024). As before, there was of CCVs and sorting endosomes (Woodman, 2000).
no significant difference among these inhibitors with The extent to which the CCV-enriched fraction was
respect to the internalization of NGF (p  0.29, K ver- contaminated with other membranes was evaluated.
sus MDC; p  0.47, K versus CPZ; p  0.69, MDC WCL was enriched 19.1-fold (n  3; p  0.001) in
versus CPZ). We conclude that NGF internalization in nucleoporin, a specific marker of nuclear membranes,
neurons is dependent, at least in part, upon the clathrin compared to CCVs (Figure 3D). To assay plasma mem-
pathway. brane contamination, we surface-iodinated PC12 cells
and isolated CCVs. We found 5,598 cpm (924 cpm;
n  3) from plasma membrane present in CCVs isolatedIsolation and Characterization
from unwarmed cells and 54,989 cpm (5,637 cpm; nof CCVs in PC12 Cells
3; p  0.001 versus unwarmed) following warming forCCVs are endocytic organelles that are derived from
2 min in the presence of NGF. This suggests that theclathrin-coated membranes. The increase in clathrin-
upper limit of plasma membrane contamination of thecoated membranes that followed NGF treatment sug-
CCV fraction is 10%. Next, we tested for the presencegested that NGF could signal to increase the number
of non-CCV endosomal membranes. While a substantialof CCVs. Isolation of CCVs generated a fraction that
contained electron-dense particles approximately 65 amount of the early endosomal marker EEA1 was de-
CCVs Are NGF-Signaling Endosomes
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Figure 4. NGF Was Internalized in CCVs
(A) NGF induced an increase in CCVs. PC12
cells were incubated with NGF (2 nM) at 4C
for 1 hr, then warmed in the continued pres-
ence of NGF for the times indicated or were
not warmed. The CCV fractions from equal
numbers of cells were lysed, and the total
protein was measured. Values are expressed
as the percent increase above that in the un-
warmed cells (n  6 or 7; two asterisks indi-
cate p  0.001 versus unwarmed).
(B) Inhibitors of clathrin-mediated endocyto-
sis blocked the NGF induction of CCVs that
occurred upon warming. PC12 cells were
treated with inhibitors or no inhibitor (none)
for 15 min at 37C and then were chilled (4C)
and incubated for 1 hr with NGF (2 nM) in
the continued presence of the inhibitors, as
appropriate. Cells were then either warmed
for 5 min at 37C (5, hatched bar) or left un-
warmed (0, solid bar). The total protein in
the CCV fractions was measured. Values are
expressed as the percent of those in un-
warmed cells treated under the same conditions (n  3 for each; two asterisks indicate p  0.001 versus warming with no inhibitor).
(C) NGF was specifically internalized into CCVs upon warming. PC12 cells were incubated with 125I-NGF (2 nM) at 4C for 1 hr and then warmed
in the continued presence of radiolabeled NGF for the times indicated. The specific activity of internalized NGF was calculated as cpm per
g total CCV protein. Values are expressed as percent increase above unwarmed controls (n  4 or 5; two asterisks indicate p  0.005 versus
unwarmed).
(D) Inhibitors of clathrin-mediated endocytosis blocked internalization of NGF into CCVs. Cells were treated as in (B), except that 125I-NGF (2
nM) was used. Specific internalization into CCVs was calculated. Values are expressed as percent of those in unwarmed cells treated under
the same conditions (n  3 for each; two asterisks indicate p  0.001 versus warming with no inhibitor).
tected in WCL, little if any of the marker was found in paralleled that for the association of clathrin with mem-
branes (Figure 1) and that for complex formation amongthe CCV fraction (Figure 3D), indicating that this fraction
was not detectably contaminated with uncoated early TrkA, CHC, and AP2 (Figure 2). We conclude that NGF
increased endocytosis through clathrin-coated mem-endosomes.
To characterize further the CCV-containing fraction, we branes.
analyzed a functional hallmark of the clathrin pathway, the
internalization of biotinylated transferrin into CCVs. Figure
NGF Was Present in CCVs
3F shows that CCVs isolated from PC12 cells treated with
To determine whether NGF was contained in CCVs, we
biotinylated transferrin dynamically accumulated this pro-
isolated CCVs from PC12 cells incubated with 125I-NGF.
tein. Taken together, the data provide compelling evi-
Consistent with the apparent internalization of NGF that
dence that the fraction isolated in these experiments
was measured in whole cells without warming, as docu-
was highly enriched in both structural and functional
mented above, radiolabeled NGF was present in CCVs
markers of the clathrin pathway and that it corresponds
isolated from unwarmed cells. The amount of NGF in
to a markedly enriched preparation of CCVs.
CCVs markedly increased with time of warming (Figures
4C and 4D). Internalization was specific, since competi-
tion with a 1000-fold excess of unlabeled NGF resultedNGF Increased the Amount of CCVs
To examine NGF effects on CCVs, PC12 cells were incu- in nearly complete inhibition of radiolabeled NGF uptake
(data not shown). The specific activity of internalizedbated with NGF (2 nM) for 1 hr at 4C and then warmed
for 0, 2, 5, or 15 min. The amount of total protein in NGF in the CCV fraction increased throughout the time
course. There was a 23% increase after 2 min of warmingCCV fractions obtained from equal numbers of cells was
measured (Figure 4A). Following 2 min of warming, CCV (p  0.001 versus unwarmed), a 38% increase after 5
min (p  0.005), and an 87% increase after 15 min (p protein was 166% of that in unwarmed cells, reflecting
a 66% increase in CCVs (p  0.001) (Figure 4A). After 5 0.001). CPZ and MDC each inhibited the internalization
of 125I-NGF into the CCV fraction (Figure 4D) that oc-min there was a 53% increase (p 0.001). The increases
induced by NGF were transient, because by 15 min the curred upon warming.
We asked to what extent NGF internalization via CCVsamount of CCV protein had returned almost to the level
found in untreated cells. Importantly, warming in the pres- was dependent on TrkA activation. For these studies,
PC12 cells were either pretreated with K252a (200 nM),ence of the vehicle control did not substantially contribute
to the formation of CCVs (5.4% increase 1.2%; n  3; an inhibitor of TrkA activation, at 37C for 15 min, or
were left untreated. All cells were then incubated withp 	 0.05). As expected from their effects on clathrin-
mediated endocytosis, CPZ and MDC blocked the NGF- 125I-NGF (2 nM) for 5 min, and the amount of NGF internal-
ized in whole cells or in CCVs was measured. In theinduced increase in CCVs (Figure 4B). The time course
for the increase in CCVs that followed NGF treatment presence of K252a, NGF internalization was decreased
Neuron
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Figure 5. CCVs Contained NGF, TrkA, and El-
ements of the Ras-MAPK Pathway
(A and L) TrkA was present in CCVs. PC12
cells were treated at 37C with NGF (2 nM)
for the times indicated or were not treated (0).
CCVs isolated from equal numbers of cells
were lysed and immunoprecipitated for TrkA.
(B) NGF was bound to TrkA in CCVs. PC12
cells were incubated with 125I-NGF (2 nM) for
1 hr at 4C and then warmed for the times
indicated in the continued presence of NGF.
CCV lysates were immunoprecipitated with a
TrkA antibody. NGF binding to TrkA in CCVs
increased markedly with warming and was
specific because there was no signal when
unlabeled NGF was present in excess (500
)
during the incubation (cc).
(C–K) The same conditions as in (A) were used
to treat samples. In (D–K), CCV lysates from
equal numbers of cells were analyzed by im-
munoblotting.
(C and L) Activated TrkA was present in CCVs
from NGF-treated cells. TrkA immunoprecipi-
tates from CCVs were immunoblotted with an
antibody to phosphotyrosine.
(D and M) Shc was present in CCVs and was
increased with NGF treatment.
(E and M) Ras was present in CCVs. CCVs from
cells treated with NGF contained more Ras.
(F and N) c-Raf was present in CCVs. The
amount of c-Raf was markedly increased by
NGF treatment.
(G and N) b-Raf was present in CCVs but did
not increase with NGF treatment.
(H and N) Mek1/2 was found in the CCV frac-
tion and was modestly increased by NGF
treatment.
(I and N) Activated Mek1/2 were present at
extremely low levels in CCVs isolated from
untreated cells but were markedly increased in CCVs from NGF-treated cells.
(J) PI-3 kinase was present in the CCV fraction and was increased by NGF treatment.
(K) Likewise, PLC was increased following NGF treatment.
to 51% (11%; n  3; p  0.05) of the untreated value. protein in treated cells, as a percent of the untreated
control (see Figure 4A). This gave a ratio for the extent ofThis finding shows that in PC12 cells, about 50% of NGF
internalization requires TrkA activation. Importantly, enrichment with treatment (Table 1). A value significantly
greater than 1 would indicate that the increase was largerK252a reduced the internalization of NGF into CCVs to
10% (6%; n  3; p  0.02) of the untreated value, than could be accounted for by the increase in CCVs. For
TrkA, neither the ratio at 2 min (0.95; p 	 0.50) nor thatindicating that a majority of clathrin-mediated NGF inter-
nalization is dependent on TrkA activation. These find- at 5 min (1.36; p  0.10) was significantly greater than
1. These data suggest that the increase in TrkA in CCVsings suggest that NGF internalization via the clathrin
pathway is dependent upon TrkA activation and repre- was due to the increase in the number of CCVs.
To determine whether NGF in CCVs was bound tosents about half of total cellular NGF internalization.
Other, non-clathrin-mediated mechanisms for NGF in- TrkA, CCVs isolated from cells warmed in the presence
of 125I-NGF were lysed and immunoprecipitated with anternalization do exist, but they are as yet poorly defined.
antibody against TrkA. Figure 5B shows a radiolabeled
band corresponding to the monomer weight of NGF. InNGF-TrkA Complexes Were Found in CCVs
We next determined whether NGF-TrkA complexes were one experiment, bands were excised from the gel and
counted. Compared to the unwarmed sample, thepresent in CCVs. Figure 5A shows that TrkA was present
in CCVs, and the amount increased following NGF treat- amount of 125I-NGF was 296% at 5 min, and 562% at 15
min. These studies show that NGF is bound to TrkA inment (Table 1). Following 2 min of NGF treatment, the
amount was 157% (Table 1), reflecting a 57% increase CCVs. They also demonstrate that the amount of NGF
bound to TrkA in CCVs was out of proportion to theabove untreated (Figure 5L). At 5 min, the increase was
108% above untreated (Figure 5L and Table 1). To clarify increase in CCV production, suggesting that TrkA recep-
tors with bound NGF are enriched in the CCV fraction.whether these changes were due to the increase in CCV
production observed with NGF treatment, the amount We expected that TrkA receptors in CCVs from NGF-
treated cells would be activated. There was very littleof TrkA in CCVs from treated cells, as a percent of the
untreated control, was divided by the amount of CCV tyrosine phosphorylated TrkA in CCVs isolated from un-
CCVs Are NGF-Signaling Endosomes
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Table 1. Quantification of Signaling Proteins Associated with CCVs
Protein Time1 (min) Percent of Untreated2 Change Relative to CCV Protein Levels3
TrkA 2 157  16.5; n  4; p  0.0002; p  0.014 versus 5 0.95  0.13; p 	 0.50
5 208  25.0; n  4; p  0.0001 1.36  0.22; p 	 0.10
p-TrkA 2 407  47.3; n  3; p  0.0040; p  0.016 versus 5 2.45  0.38; p  0.05*
5 610  83.4; n  3; p  0.0040 3.99  0.33; p  0.005*
Shc 2 153  9.7; n  3; p  0.0024; p  0.015 versus 5 0.92  0.09; p 	 0.20
5 226  19.5; n  3; p  0.0014 1.48  0.18; p  0.05*
Ras 2 208  25.4; n  5; p  0.00040; p 0.0001 versus 5 1.25  0.21; p  0.10
5 316  48.7; n  5; p  0.00031 2.07  0.40; p  0.005*
Ras-GTP 2 179  9.2; n  3; p  0.0017; p 0.0043 versus 5 1.08  0.09; p 	 0.20
5 242  16.3; n  3; p  0.0016 1.58  0.40; p  0.05*
C-Raf 2 306  22.5; n  3; p  0.00016; p 0.0001 versus 5 1.84  0.14; p  0.001*
5 517  61.6; n  3; p  0.0001 3.38  0.40; p  0.001*
B-Raf 2 111  11.8; n  3; p  0.63; p  0.65 versus 5 0.67  0.07; p  0.01*
5 102  16.4; n  3; p  0.995 0.66  0.11; p  0.05*
Mek 1/2 2 228  45.6 n  3; p  0.041; p  0.73 versus 5 1.37  0.27; p 	 0.2
5 209  21.2; n  3; p  0.0067 1.37  0.14; p 	 0.05
p-Mek 1/2 2 835  34.5; n  3; p  0.0001; p 0.0005 versus 5 5.03  0.21; p  0.0001*
5 460  9.4; n  3; p  0.0001 3.01  0.06; p  0.0001*
p42 total Erk 2 105  1.0; n  3; p  0.1; p  0.051 versus 5 0.63  0.01; p  0.001*
5 108  0.76; n  3; p  0.06 0.70  0.01; p  0.001*
p44 total Erk 2 101  0.81; n  3; p  0.30; p  0.34 versus 5 0.61  0.01; p  0.001*
5 100  0.53; n  3; p  0.42 0.65  0.005; p  0.001*
p42 p-Erk 2 283  6.0; n  5; p  0.0001; p 0.0001 versus 5 1.70  0.10; p  0.001*
5 739  22.7; n  5; p  0.0004 5.62  0.76; p  0.001*
p44 p-Erk 2 358  22.8; n  5; p  0.0002; p 0.0001 versus 5 2.16  0.21; p  0.001*
5 860  82.8; n  5; p  0.0001 4.83  0.33; p  0.001*
phospho-Elk 2 275  28.1; n  3; p  0.012; p 0.0090 versus 5 1.66  0.20; p  0.05*
5 504  55.4; n  3; p  0.0091 3.29  0.50; p  0.02*
1 Time of NGF treatment.
2 p values report the significance (*) of differences comparing treated to untreated sample or the difference between 2 and 5 min of NGF
treatment.
3 This ratio was calculated by dividing the amount of the signaling protein in CCVs from treated cells, as percent of the untreated, by the
amount of CCV protein in treated cells, as percent of the untreated (see Figure 4A).
treated cells. In contrast, activated TrkA was present in cantly exceeded that for CCV protein (Table 1). Ras was
also contained in CCVs. While some Ras was presentthe CCVs of treated cells at both 2 and 5 min (Figure
5C). Following treatment, there was a 307% increase in in the CCVs of untreated cells, the amount was signifi-
cantly increased by NGF treatment at both 2 and 5 minphospho-TrkA at 2 min and a 510% increase at 5 min
(Figure 5L and Table 1). Therefore, the levels of phos- (Figure 5E). The increases followed a time course similar
to that for Shc (Figure 5M and Table 1). To determinephorylated TrkA were dramatically increased with re-
spect to CCV protein at both 2 and 5 min (Table 1). We whether activated Ras was present, we affinity-precipi-
tated the GTP bound form of Ras, using a GST-fusionconclude that NGF induces the formation of CCVs that
are enriched in activated TrkA and that NGF remains protein consisting of the Ras binding domain of Raf-1.
We observed increases in Ras-GTP at both 2 and 5 minbound to activated TrkA in this organelle.
of NGF treatment (Figure 5M and Table 1). By 5 min, the
amounts of both Ras and activated Ras were signifi-Evidence that CCVs Serve as a Platform that Links
NGF Signaling to Activation of MAPK cantly enriched with respect to CCV protein (Table 1).
While there was little c-Raf in CCVs from untreatedTo assess the ability of activated TrkA receptors in CCVs
to signal, we asked whether proteins known to participate cells, the amount was markedly increased following NGF
treatment (Figures 5F and 5N) and was significantly inin the Ras-MAPK signaling pathway were associated with
CCVs. Shc is an adaptor protein that participates in a excess of CCV protein (Table 1). In contrast, while b-Raf
was present (Figure 5G), the levels did not increase withmulticomponent complex to link activated TrkA to Ras,
C-Raf, Mek, the MAPKs, Erk1, and 2. Several of these NGF treatment (Figure 5N and Table 1). Mek1/2 were
also increased at both 2 and 5 min of NGF treatmentproteins were present in CCVs from untreated cells (Fig-
ures 5D, 5E, 5H, 6A). Shc was present, as was Ras, (Figure 5N and Table 1), but they were not enriched with
respect to CCV protein (Table 1). However, at both timeMek1/2, and Erk1/2. However, we detected only a small
amount of C-Raf and very little of the activated forms points, phospho-Mek1/2 were markedly increased (Fig-
ures 5I and 5N and Table 1) and were significantly en-of Ras, Mek1/2, and Erk1/2.
NGF treatment resulted in several marked changes in riched relative to CCV protein.
Next, we asked whether activated Erk1/2 were associ-the signaling proteins present within CCVs. First, we
noted that NGF treatment caused an increase in the ated with CCVs. They were present in both treated and
untreated cells (Figure 6A), and the amount of theseamount of the 66 kDa form of Shc associated with CCVs
(Figures 5D and 5M). At 5 min, the increase in Shc signifi- proteins was not increased by NGF treatment (Figure
Neuron
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Figure 6. NGF Induced the Formation of Sig-
naling Endosomes
(A and F) Erk1/2 was found in CCVs. Samples
were produced as in Figure 5A. CCV lysates
were immunoblotted with an antibody against
Erk1/2. There was no increase in total Erk1/2
in CCVs following NGF treatment.
(B and F) However, the same blot reprobed
with anti-phospho-Erk1/2 showed a dramatic
increase in activated Erk in CCVs isolated
from NGF-treated cells at both 2 and 5 min.
(C) Characterization of the relative levels of
total Erk1/2 and activated Erk1/2, comparing
whole cell lysates (WCL) and whole cell mem-
brane (WCM) fractions, of cells treated with
NGF for 5 min.
(D and G) Comparison of total Erk1/2 and
activated Erk1/2 in the WCM and CCV frac-
tions, normalized for protein, in NGF-treated
(2 nM, 37C, 5 min) and untreated cells. While
absolute levels of total and activated Erk1/2
were lower in the CCV fraction, the amount
of activated Erk1/2 relative to total Erk1/2 was
enriched 4.5-fold in CCVs.
(E and H) CCVs from NGF-treated cells trans-
mitted a signal in a cell-free assay. PC12 cells
were treated at 37C with NGF (2 nM) for the
times indicated or were not treated (0). Fol-
lowing NGF treatment, CCVs exhibited a
marked increase in the ability to phosphory-
late the Elk-GST substrate.
6F and Table 1). Indeed, relative to CCV protein levels, for the CCV fraction. The relative enrichment of activated
Erk1/2 in CCVs raised the possibility that these mem-the amounts of p42 and p44 Erk were decreased (Table
1). Of note, however, activated Erk1/2 were present es- branes could be used to propagate the MAPK signal.
sentially only in CCVs from NGF-treated cells (Figure
6B), and the degree of phosphorylation increased be- NGF-Induced Signaling from CCVs
tween 2 and 5 min. The pattern was highly reminiscent To test the signaling potential of CCVs, we examined
of that seen for the levels of Shc, Ras, and c-Raf (Figures the capacity of isolated CCVs to phosphorylate Elk, a
5D–5F). Phosphorylated Erk1/2 were both significantly well-known substrate of Erk. We used as substrate an
enriched in CCVs following NGF treatment (Table 1). Elk-GST fusion protein that includes the Elk domain nor-
These studies provide evidence for the presence of mally phosphorylated by Erk1/2 in vivo. Consistent with
components of the Ras-MAPK pathway in CCVs from our findings for activated Erk1/2 in CCVs, there was a
untreated cells, and they document significant changes marked increase in activity associated with the CCVs
in response to NGF treatment. The findings indicate that isolated from cells treated with NGF (Figure 6E). NGF
NGF signaling results in the increasing presence within induced a nearly 2-fold increase in the ability to phos-
CCVs of activated TrkA, Shc, Ras, activated Ras, c-Raf, phorylate the Elk-GST substrate at 2 min and a 4-fold
and activated Mek1/2 and suggest that these changes increase at 5 min (Figure 6H and Table 1). We conclude
are linked to the activation of Erk1/2. that CCVs can serve as a platform for propagating the
NGF signal through the Ras-MAPK pathway.
Relative Enrichment of Activated Erk1/2 in CCVs
We asked whether there was enrichment of activated Clathrin-Mediated Membrane Trafficking
and the Activation of Erk1/2Erk1/2 in CCVs. Cell membranes appeared to be an
important locus for MAPK signaling, as we found similar Since inhibition of clathrin-mediated endocytosis blunted
the internalization of NGF and since CCVs were enrichedlevels of Erk1/2 in whole cell membranes (WCM) and in
WCL (Figure 6C). Moreover, the levels of activated Erk1/2 in activated Erk1/2 following NGF treatment, we asked
whether clathrin-mediated endocytosis played a role inwere similar in these fractions (Figure 6C). Importantly,
while in NGF-treated cells the absolute levels of total the activation of the Ras-MAPK pathway. We assessed
the ability of NGF to induce the phosphorylation of Erk1/2Erk1/2 and activated Erk1/2 were lower in the CCV frac-
tion than in the WCM fraction (Figure 6D), the amount in PC12 cells and DRG neurons treated with MDC. Figure
7A shows phospho-Erk1/2 immunostaining in an un-of activated Erk1/2 relative to total Erk1/2 was enriched
4.5-fold in CCVs (0.7; n  3; p  0.001) (Figure 6G). treated PC12 cell, and Figure 7F shows an untreated
DRG neuron. Treatment with NGF resulted in a dramaticThis value was determined by calculating the ratio of
phosphorylated Erk1/2 to total Erk1/2 for the WCM and increase in phospho-Erk1/2 immunostaining in both
PC12 cells (Figure 7B) and DRG neurons (Figure 7G).the CCV fractions (Figure 6G). The ratio was 0.183
(0.025; n  3) for the WCM and 0.815 (0.065; n  3) However, in the presence of MDC, activation of Erk1/2
CCVs Are NGF-Signaling Endosomes
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Figure 7. Inhibitors of Clathrin-Mediated Internalization Suppressed Erk Activation
(A–E) PC12 cells were incubated with MDC and then treated with NGF (2 nM) for 2 min at 37C or left untreated.
(A) Phospho-Erk1/2 immunostaining of an untreated PC12 cell.
(B) Dramatic increase in phospho-Erk1/2 immunostaining in a PC12 cell treated with NGF.
(C) MDC did not alter phospho-Erk1/2 immunostaining in untreated PC12 cells, but completely blocked the induction of such staining in cells
treated with NGF (D).
(E) Biochemical characterization of the effect of MDC on Erk1/2 activation. Cells treated with NGF exhibited a robust increase in phosphorylated
Erk1/2 in the WCL. MDC completely blocked this phosphorylation without inhibiting TrkA activation (bottom panel).
(F–L) DRG neurons were treated as above.
(F) Phospho-Erk1/2 immunostaining in an untreated DRG neuron.
(G) Dramatic increase in phospho-Erk1/2 staining following NGF treatment.
(H and I) MDC blocked Erk1/2 activation without altering baseline phospho-Erk1/2 immunostaining.
(J) Prominent phospho-Erk1/2 immunostaining was detected in the neurites of DRG neurons following NGF treatment.
(K) MDC effectively inhibited the activation of Erk1/2 at the level of the neurites and cell bodies.
(L) As in (E), MDC blunted Erk1/2 activation in DRG neurons without altering phosphorylation of TrkA (bottom panel). The scale bars for (A–D)
and (F–I) are 5 m; the scale bar for (J–K) is 10 m.
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was inhibited (Figures 7D and 7I) without affecting Erk1/2 The Signaling Endosome Hypothesis and CCVs
Retrograde signaling of neurotrophins play an essentialactivation in untreated cells (Figures 7C and 7H). Interest-
ingly, the inhibition of Erk activation in DRG neurons also role in the development and maintenance of the nervous
system (Sofroniew et al., 2001). The mechanism(s) thatoccurred at the level of the neurites (compare Figures
7J and 7K). The results were confirmed biochemically mediate this form of signaling are as yet poorly defined
(Hendry and Crouch, 1993; Campenot, 1994). Possibili-by probing WCL from cells treated with NGF in the pres-
ence or absence of MDC. As shown in Figures 7E and 7L, ties include both vesicular and nonvesicular transport.
In demonstrating that signaling endosomes can be iso-while MDC failed to block the NGF-induced activation of
TrkA, it did block the phosphorylation of Erk1/2 in PC12 lated from cells treated with NGF, the evidence provided
herein supports the signaling endosome hypothesis. Re-cells and in DRG neurons. Using potassium depletion
to inhibit the clathrin pathway in PC12 cells and in DRG garding the proposed alternatives for retrograde signaling,
the possibility of wave-like retrograde movement of down-neurons, we confirmed that NGF-induced activation of
Erk1/2 was markedly decreased (data not shown). stream signaling effectors is most intriguing (Senger and
Campenot, 1997), although the known kinetics of signalHence, we conclude that clathrin-mediated trafficking
of the NGF-TrkA complex plays an important role in transport do not favor such a regenerating wave phe-
nomenon (Fitzsimonds and Poo, 1998). Nevertheless,translating TrkA activation to downstream signaling
events leading to the activation of Erk1/2. existing data are insufficient to point to the signaling
endosomes hypothesis as the only means by which neu-
trophin signals are moved from axon terminals to cell
CCVs Contain Components of Other bodies.
Signaling Pathways The signaling endosome hypothesis raises the possi-
NGF signals through a diverse set of pathways (Sofro- bility that trophic factor signaling regulates the formation
niew et al., 2001). We entertained the possibility that of endosomes. The current study supports this idea by
protein components of non-MAPK pathways might be showing that activated TrkA is present in complex with
present in the CCV fraction. We found that the p85 sub- CHC and AP2. As suggested by earlier studies on RTKs,
unit of PI-3 kinase (Figure 5J) and PLC (Figure 5K) were activated receptors may be trafficked to clathrin-coated
both present in CCVs and that their levels increased pits or may be preferentially retained in these mem-
with NGF treatment. The levels of PI3-K were quantified. branes (Schmid, 1997). In showing that the time course
Relative to the untreated controls, the levels of PI3-K for TrkA complex formation with AP2 and CHC matches
were 376% (20.7%; n  3; p  0.002) at 2 min and that for clathrin recruitment to membranes, our findings
589% (72.0%; n  3; p  0.0002) at 5 min of NGF suggest the important additional possibility that TrkA
treatment. We were unable to detect the presence of activation locally induced the formation of clathrin-
Akt or phosphorylated Akt in the CCV fraction, either in coated membranes. The formation of complexes con-
the presence or absence of NGF treatment (data not taining activated TrkA and clathrin in NGF-treated cells
shown). Additional studies will be needed to address suggested that NGF signaling might be communicated
whether or not NGF signals through PI3-K in CCVs. to the cell interior through the endocytosis of NGF bound
to TrkA in CCVs. Isolation of a purified CCV fraction
allowed us to test this idea. The membranes we isolatedDiscussion
were highly enriched in both structural and functional
markers of clathrin-coated membranes. Importantly,Neurotrophin-induced signals must be conveyed from
they showed little contamination by the plasma mem-the presynaptic terminal to the cell body to induce pleio-
brane and were not detectably contaminated by earlytropic effects on survival and differentiation. In the stud-
endosomes, the only other endosomal compartmenties reported herein, we addressed the possibility that the
likely to contribute to NGF endocytosis or signaling atclathrin pathway plays an important role in facilitating the
the time points monitored. We found that NGF was pres-movement of the neurotrophin signal from the cell surface
ent in the CCV fraction and that this NGF was specificallyto internal membranes. We showed that NGF signaling
bound to TrkA, suggesting that the receptor would con-increased the formation of clathrin-coated membranes
tinue to be activated following endocytosis. Indeed, acti-containing activated TrkA in complex with AP2 and CHC
vated TrkA was present in CCVs from NGF-treated cellsand that these membranes gave rise to CCVs containing
and was markedly enriched with respect to CCV protein.NGF bound to TrkA, activated TrkA, proteins of the Ras-
Pointing to a critical role for TrkA activation in movingMAPK pathway, and activated Erk1/2. Importantly, the
NGF into CCVs, inhibition of TrkA with K252a virtuallyNGF-induced increase in activated Erk1/2 within CCVs
abolished the movement of NGF into CCVs. Our findingswas correlated with their increased ability to signal in a
are evidence that NGF signals through TrkA to regulatecell-free assay to phosphorylate Elk. Finally, treatments
the formation of clathrin-coated membranes and therebythat inhibited clathrin-mediated internalization of NGF
the formation of CCVs containing NGF bound to TrkA.suppressed the activation of Erk1/2 downstream from
TrkA activation. We conclude that NGF signaling in-
duces the formation of CCVs that serve as signaling NGF Signaling from CCVs
To test the signaling potential of CCVs, we askedendosomes and that the generation of signaling endo-
somes links TrkA activation to activation of the Ras- whether downstream signaling proteins were present.
In CCVs from untreated cells, we found many of theMAPK pathway. We speculate that CCVs are one source
for generating signaling endosomes that move the NGF components that link NGF signaling through TrkA to
Erk1/2. With NGF treatment there were marked changes.signal from axon terminals to neuron cell bodies.
CCVs Are NGF-Signaling Endosomes
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Together with the increase in activated TrkA, there were cytosis of RTKs to Erk1/2 activation have been produced
increases in c-Raf, Shc, and Ras that significantly ex- for EGFR (Vieira et al., 1996), insulin receptor (Ceresa
ceeded the increase in CCV protein, suggesting en- et al., 1998), IGFR (Chow et al., 1998), and TrkA (York
hanced recruitment of these proteins. In addition, there et al., 2000) (see Leof, 2000, for review). The existence
was also the appearance of increasing levels of the on CCVs of a signaling complex for activating the Ras-
activated forms of Ras and Mek1/2. Significantly, phos- MAPK pathway helps to explain these findings. The pos-
phorylated Erk1/2 were present essentially only in CCVs sible physiological significance of CCV-based MAPK
isolated from NGF-treated cells, and these kinases were signaling is supported by data showing that MDC inhib-
able to access substrate, as judged by their ability to ited both neurite outgrowth and survival of rat cerebellar
robustly phosphorylate Erk. These data give further evi- neurons (Gilad and Gilad, 1986) and that inhibition of
dence that CCVs are the source of the NGF signal in NGF internalization in PC12 cells using a dynamin mu-
our preparations. A contaminant would not be expected tant blunted neurite outgrowth (Zhang et al., 2000).
to show changes that were so dramatic, varied across Taken together with our findings, these data point to an
treatments, and differed from protein to protein (Table 1). important role for endocytosis in signaling important for
Our findings expand upon the signaling endosome neuronal functions. We conclude that the formation of
hypothesis (Hendry and Crouch, 1993; Beattie et al., clathrin-coated membranes containing the NGF-TrkA
1996; Grimes et al., 1996, 1997; Leof, 2000) by showing complex together with other signaling components, the
that signaling endosomes serve as more than a mem- internalization of the receptor-ligand complex into CCVs
brane-based source of the ligand-receptor complex. where it gains access to critical signaling components,
Rather, they harbor a number of additional signaling or both, are integral steps in the engagement of the
components that contribute critically to the activation MAPK pathway.
of downstream signaling events. Indeed, our findings Our findings are evidence that in both neurons and
suggest that NGF-induced TrkA activation modifies pre- PC12 cells, NGF acts upon the clathrin pathway to create
existing extended protein complexes to form a coherent a membrane-based platform to deliver the NGF signal
signaling machine that is derived from clathrin-coated to the cell interior. The most compelling context for this
membranes. The formation of such membrane-based model is in the retrograde transport of the neurotrophic
complexes would be ideal for controlling the locus of signal from the axon terminal to the cell body. While
signaling within cells. Through the continued activation CCVs are one source of signaling endosomes, they are
of TrkA and its downstream signaling partners in these short-lived intermediates in membrane trafficking, and
membranes, signaling endosomes could propagate sig- several intracellular membrane sorting events are prob-
nals that are long lived, robust, and of high fidelity. ably required to produce the signaling endosomes that
Conceivably, several different signaling components are transported retrogradely in axons. The important
could be assembled on the same signaling endosome, possibility must also be explored that some signaling
and endosomes may recruit a dynamic array of different endosomes are derived from membrane trafficking
signaling components during intracellular transit from events that do not involve clathrin.
the axon terminal to the cell body. For example, recent
data have pointed to a role for Erk5 in retrograde signal-
Experimental Proceduresing at neuron cell bodies in compartmentalized cultures
(Watson et al., 2001). Given that Ras is upstream from
ReagentsErk5 activation and that we provide evidence of contin-
TD.1, a mouse antibody (Ab) against CHC, was from BAbCo (Rich-
ued activation of Ras in signaling endosomes, it is possi- mond, CA). X22, a mouse Ab against CHC, was from Affinity Biorea-
ble that various Ras effector molecules, including Erk5, gents (Golden, CO). 100/2, a mouse Ab against -AP2, was from
could be engaged in a manner that is dependent upon Sigma (St. Louis, MO). From Cell Signaling Technology (Beverly,
MA), we obtained 9141, a rabbit Ab against TrkA specifically phos-subcellular localization of the signaling endosome. How-
phorylated on tyrosine 490; 9181, a rabbit Ab that recognizes onlyever, it is important to note that evidence indicating the
Elk-1 phosphorylated on serine 383; 9101, a rabbit Ab specific foractivation of CREB in the cell bodies of compartmental-
Erk1/2 that is phosphorylated on threonine 202 and tyrosine 204;ized neuron cultures treated distally with NGF is consis- 9121, a rabbit Ab against Mek1/2 phosphorylated specifically on
tent with a role for retrogradely transported Erk1/2 (Ric- serines 217 and 221; 9272, a rabbit Ab specific for Akt; 9271, a
cio et al., 1997; Watson et al., 1999; Cavanaugh et al., rabbit Ab raised against Akt phosphorylated specifically on serine
2001). Moreover, the continued activation of Erk1/2 on 473; and 9102, a rabbit Ab generated against p42 and p44 Erk
(Erk1/2). From Upstate Biotechnology (Lake Placid, NY), we pur-signaling endosomes is consistent with previous work
chased 06574, a rabbit Ab against TrkA; 06372, a rabbit Ab againstshowing the retrograde transport of activated Erk1/2 in
Ras; 06203, a rabbit Ab against Shc; 05217, a mouse Ab specificligated rat sciatic nerve (Reynolds et al., 2001). Future
for PI-3 kinase; and 4G10, a mouse Ab against phosphotyrosine.
studies addressing the role of various Ras effector mole- G158A, a chicken Ab to TrkA, was from Promega (Madison, WI).
cules in signaling from endosomes will be important to N43620, a mouse Ab to nucleoporin p62 was obtained from Trans-
fully understanding neurotrophin signaling. duction Laboratories (Lexington, KY), as was R19120, a mouse Ab
It is apparent from our data that membrane bound against c-Raf, and E41120, a mouse Ab specific for EEA1. RTA, a
rabbit Ab to TrkA, was the kind gift of Louis Reichardt (UCSF). HRP-elements of the MAPK pathway could play an important
conjugated secondary Abs were from Santa Cruz Biotechnologyrole in intracellular signaling. The specific activity of
(Santa Cruz, CA), as was SC7383, a mouse Ab raised against Erkactivated Erk1/2 in CCVs was enriched relative to whole
phosphorylated on tyrosine 204; SC166, a rabbit Ab specific for
cell membranes. Moreover, inhibition of clathrin-medi- b-Raf; SC436, a rabbit anti-Mek Ab; SC7290, a mouse Ab specific
ated endocytosis of NGF was correlated with signifi- for PLC; and SC598, a rabbit Ab raised against rab5.
cantly blunted activation of Erk1/2 in both PC12 cells Mouse NGF was prepared as previously described (Mobley et al.,
1985). 125Iodine (IMS-30) was from Amersham Pharmacia Biotechand DRG neurons. Similar data linking inhibition of endo-
Neuron
812
(Piscataway, NJ). The Elk-1 fusion protein, 9184, was from Cell Sig- for 15 min at 37C. In some experiments, in the continued presence
of the inhibitors, cells were then chilled to 4C and incubated for 1naling Technology. Glucose oxidase was from ICN (Costa Mesa,
CA). All other chemical reagents were from Sigma. Sprague Dawley hr with 125I-NGF (2 nM). In other experiments, 125I-NGF (2 nM) was
added to cells at 37C in the continued presence of the inhibitor.rats were obtained from Charles River Labs (Willmington, MA). Aga-
rose-conjugated Raf-1 Ras binding domain was obtained from Up- To measure nonspecific uptake, a 1000-fold excess of NGF was
included in some experiments. After internalization for various times,state Biotech.
cells were chilled and washed, surface bound NGF was stripped
using 0.2 M acetic acid and 0.5 M NaCl, unbound NGF was removed,Cell Culture and Treatments
and the cells were lysed. Protein-normalized lysates were assayedKB PC12 cells (gift of R. Kelly, UCSF) were maintained as previously
for cpm, and the results were corrected to reflect specific internaliza-described (Beattie et al., 2000). DRG neurons were isolated from
tion (total internalization minus nonspecific internalization). Nonspe-E15-16 Sprague Dawley rat pups following previously established
cific internalization averaged 10%–20% of total. The values shownmethods (Chan et al., 1998). Dorsal root ganglia were sterilely dis-
are expressed as pg of NGF internalized per g of cellular protein.sected in dissection media (Leibovitz L-15 medium with L-glutamine,
10% fetal bovine serum [FBS], and 30 g/mL gentamicin). Neurons
Immunofluorescence and Microscopywere plated on either collagen-coated coverslips or on polyornith-
For analysis of CHC redistribution, serum-deprived PC12 cells orine-coated tissue culture plates in maintenance media (sodium
DRG neurons were analyzed as previously described (Beattie etphosphate-free MEM with Earle’s salts, L-glutamine, 10% FBS, 20
al., 2000). For analysis of phospho-Erk by immunostaining, serum-g/mL gentamicin, 4.5 g/L D-glucose, and 100 ng/mL NGF). Pure
deprived PC12 cells or DRG neurons were incubated in PGBH forpopulations of DRG neurons were selected with antimitotic media
15 min at 37C, followed by addition of MDC, as appropriate, and(maintenance media plus N2 supplement, 2 mM uridine, and 2 mM
incubation for a further 15 min. Cells were incubated with NGF (2 nM)fluoro-2-deoxyuridine). Cells were maintained for 3–5 days in selec-
for 2 min at 37C, then washed, fixed, processed for immunostaining,tion media. Prior to the start of experiments, cells were rinsed twice
and observed with a Bio-Rad (Hercules, CA) MicroRadiance AG-2with serum-free media, then maintained overnight in low-serum me-
confocal microscope as previously described (Beattie et al., 2000).dia free of NGF. Two hours prior to treatment, the cells were rinsed
Electron microscopy of the CCV fraction was performed using stan-twice with serum-free media and then incubated under serum-free
dard methods of glutaraldehyde fixation to formar-carbon Ni-grids,conditions until the initiation of treatment.
osmium tetroxide postfixation, and staining with tannic acid andFor all PC12 cell experiments, cell growth media was changed
uranyl acetate (Peeler et al., 1993).to DMEM supplemented with 1% horse serum 16–20 hr prior to
experimentation. Prior to experiments, cells were removed from
their plates with calcium-magnesium-free PBS (CMF-PBS) at 37C, Iodination
resuspended in PGBH (1 mg/mL glucose, 1 mg/mL BSA, and 10 NGF iodination was performed essentially as described (Grimes et
mM HEPES, in PBS [pH 7.4]) at the same temperature, distributed al., 1996). Typical iodinations produced NGF with specific activity of
into 1 ml aliquots, and rotated for 15 min to allow cells to equilibrate. 150–200 cpm/pg. For surface iodination, chilled PC12 cells were resus-
With the exception of experiments measuring internalization of pended in iodination reaction buffer (25 g/mL glucose oxidase [ca.
125I-NGF in whole cells, all treatments were performed in suspension, 0.5 U], 50 g/mL lactoperoxidase [ca. 10 U], 500 g D-glucose, 300
on an equal number of cells, at 37C. For membrane-association Ci 125Iodine in PBS) and rotated for 30 min at 4C. This reaction
studies (3 
 107 –5 
 107 cells per condition), for complex formation was quenched by PBS containing 10% horse serum and 5% FBS
experiments (3
 107 –5
 107 cells per condition), and for all experi- at 4C. Cells were then resuspended in ice-cold PGBH, and either
ments in which CCV fractions were examined by Western blotting left unwarmed or warmed in the presence of NGF (2 nM). Warmed
(15 
 107 –50 
 107 cells per condition), NGF (50 ng) in 50 l PGBH samples were chilled on ice, the supernatant was removed from all
was added to each 1 ml aliquot at 37C for the appropriate time. samples, cells were resuspended in ice-cold permeabilization
For experiments in which pharmacological inhibitors were used, the buffer, and CCVs were prepared as described.
drug was added in a small volume following the equilibration step,
and the cell suspensions were then rotated for an additional 15 min Synaptosome Preparation
at 37C. Hippocampi were removed from adult Sprague Dawley rats and
For examining NGF internalization into CCVs (15 
 107 –50 
 107 placed into 10 ml of ice-cold homogenization buffer (0.32 M sucrose,
cells per condition) and experiments examining the amount of CCVs 10 mM Tris [pH 7.0]). A crude synaptosomal pellet suitable for analy-
(15 
 107 –50 
 107 cells per condition), cell suspensions were sis of synaptic function was isolated essentially as described (Wei
chilled to 4C for 15 min. NGF (50 ng) in 50 l of PGBH at 4C was et al., 1990). These synaptosomes were equilibrated by incubation
then added to each 1 ml aliquot, and the cell suspensions were in PGB for 20 min at 37C, then treated with 50 ng/mL NGF, chilled,
rotated at 4C for 1 hr. After thus allowing for receptor occupancy and resuspended in 1 ml of MES permeabilization buffer. A total
at a temperature that inhibits membrane trafficking, cell suspensions membrane fraction was obtained by freeze-thawing the synaptosomes
were warmed to 37C or were not warmed. Following warming, cell three times, followed by centrifugation at 100,000 
 g for 1 hr at 4C.
suspensions were rapidly chilled and then either resuspended in
the buffer used to isolate CCVs or lysed. Cell Fractionation
8,000 
 g Membrane Isolation
Inhibition of the Clathrin Pathway Following treatment, cells were resuspended in MES buffer (25 mM
For K-depletion experiments, cells were rinsed twice with depletion 2-[N-morpholino]ethanesulfonic acid [MES], 150 mM NaCl, 10 mM
buffer (100 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 1 mg/mL D-glucose, EDTA, 1 mM sodium orthovanadate, 1 mM PMSF, 10 g/mL aproti-
50 mM HEPES [pH 7.4]). Cells were then incubated 5 min at 37C nin, 1 g/mL leupeptin [pH 6.5]) at 4C and permeabilized using a
in hypotonic shock buffer (depletion buffer diluted 1:1 in water). Balch homogenizer, essentially as described (Beattie et al., 2000).
Shock was terminated by washing cells in depletion buffer and The suspension, which contained permeabilized cells (cell ghosts),
incubating for 30 min at 37C. In control experiments, cells were intracellular membranes, and cytosol, was centrifuged at 8,000 

incubated in recovery buffer (depletion buffer plus 10 mM KCl) for g for 35 min at 4C. This generated a pellet equivalent to fractions
30 min prior to treatment. Pharmacological inhibition of the clathrin P1 plus P2, as characterized in our earlier work (Grimes et al., 1996).
pathway was elicited by incubation of cells in either 50 M MDC or This pellet, enriched for plasma membrane and the heaviest mem-
100 M CPZ for 15 min prior to initiation of treatment. branes released from cells, was washed once with fresh MES buffer
and then recentrifuged at 8,000 
 g for 35 min
100,000 
 g Membrane IsolationInternalization of NGF Measured in Whole Cells
To measure the effect of clathrin inhibitors on NGF internalization, Cells were permeabilized as described above. The permeabilized
suspension was centrifuged at 1,000 
 g for 10 min to separatePC12 cells (1 
 107 –3 
 107 cells per condition) or DRG neurons
(3 
 106 cells per condition) were subjected to potassium depletion cell ghosts from released intracellular membranes and cytosol. The
supernatant was diluted in MES buffer and centrifuged at 100,000 
or incubated with either 100 M CPZ, 50 M MDC, or no additive
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g for 1 hr at 4C. This generated a pellet equivalent to fractions NGF actions: potential implications for neurodegeneration. Cold
Spring Harb. Symp. Quant. Biol. 61, 389–406.P2 plus P3 (Grimes et al., 1996). The pellet contained intracellular
membranes and was essentially free of plasma membrane and cytosol. Beattie, E.C., Howe, C.L., Wilde, A., Brodsky, F., and Mobley, W.C.
Whole Cell Membrane (WCM) Isolation (2000). NGF signals through TrkA to increase clathrin at the plasma
For DRG neurons, suspensions were permeabilized by three rounds membrane and enhance clathrin-mediated membrane trafficking.
of freeze-thaw. The material was then centrifuged at 100,000 
 g J. Neurosci. 20, 7325–7333.
for 1 hr at 4C, and the resulting pellet was considered to be WCM.
Bhattacharyya, A., Watson, F., Bradlee, T., Pomeroy, S., Stiles, C.,
PC12 cells were permeabilized with a Balch homogenizer, as de-
and Segal, R.A. (1997). Trk receptors function as rapid retrograde
scribed above, and the suspension was then subjected to a 100,000

signal carriers in the adult nervous system. J. Neurosci. 17, 7007–
g spin for 1 hr to generate the WCM pellet.
7016.
CCV Isolation
Campenot, R.B. (1994). NGF and the local control of nerve terminalThe isolation scheme used to purify CCVs was a modification of an
growth. J. Neurobiol. 25, 599–611.established protocol (Maycox et al., 1992). Following treatment, cells
were resuspended in CCV isolation buffer (100 mM MES, 1 mM Casaccia-Bonnefil, P., Gu, C., and Chao, M.V. (1999). Neurotrophins
EGTA, 2 mM MgCl2, 0.02% sodium azide, 1 mM -mercaptoethanol, in cell survival/death decisions. Adv. Exp. Med. Biol. 468, 275–282.
1 mM sodium orthovanadate, 1 mM PMSF, 10 g/mL aprotinin, 1 Cavanaugh, J.E., Ham, J., Hetman, M., Poser, S., Yan, C., and Xia,
g/mL leupeptin [pH 6.5]), triturated twice with a 22-gauge needle Z. (2001). Differential regulation of mitogen-activated protein kinases
to produce a single-cell suspension, then permeabilized by five ERK1/2 and ERK5 by neurotrophins, neuronal activity, and cAMP
complete passes through a Balch homogenizer. The permeabilized in neurons. J. Neurosci. 21, 434–443.
cell suspension was centrifuged at 1,000 
 g for 10 min at 4C to
Ceresa, B.P., Kao, A., Santeler, S., and Pessin, J.E. (1998). Inhibitionremove cell ghosts. The supernatant, S1, was diluted with fresh CCV
of clathrin-mediated endocytosis selectively attenuates specific in-buffer, layered onto a 5% glycerol pad in CCV buffer, and centrifuged
sulin receptor signal transduction pathways. Mol. Cell. Biol. 18,at 100,000 
 g for 1 hr at 4C. The pellet was resuspended by gentle
3862–3870.trituration into CCV buffer. The suspension was mixed 1:1 with CCV
Chan, J.R., Phillips, L., and Glaser, M. (1998). Glucocorticoids andbuffer containing 12.5% (wt/vol) ficoll and 12.5% (wt/vol) sucrose,
progestins signal the initiation and enhance the rate of myelin forma-then centrifuged at 40,000
 g for 40 min at 4C. S4, the supernatant
tion. Proc. Natl. Acad. Sci. USA 95, 10459–10464.from this centrifugation, was diluted 1:5 in fresh CCV buffer and
then centrifuged at 100,000 
 g for 1 hr at 4C. P5, the pellet from Chow, J.C., Condorelli, G., and Smith, R.J. (1998). Insulin-like growth
this round of centrifugation, was used for some experiments. In factor-I receptor internalization regulates signaling via the Shc/mito-
others, P5 was gently resuspended in CCV buffer and centrifuged gen-activated protein kinase pathway, but not the insulin receptor
at 16,000 
 g for 20 min at 4C. The supernatant, S6, was diluted substrate-1 pathway. J. Biol. Chem. 273, 4672–4680.
1:1 with CCV buffer, layered onto an 8% (wt/vol) sucrose pad pre- Davies, P.J., Cornwell, M., Johnson, J., Reggianni, A., Myers, M.,
pared in CCV buffer made with D2O, and centrifuged at 112,700 
 and Murtaugh, M.P. (1984). Studies on the effects of dansylcadaver-
g for 2 hr at 4C. The pellet resulting from this centrifugation was ine and related compounds on receptor-mediated endocytosis in
P7. P5 and P7 were both highly enriched in markers of CCVs. cultured cells. Diabetes Care 7 (Suppl. 1), 35–41.
Ehlers, M.D., Kaplan, D., Price, D., and Koliatsos, V.E. (1995). NGF-
Elk Phosphorylation Assay stimulated retrograde transport of trkA in the mammalian nervous
CCVs isolated as described above were resuspended in 25 l of system. J. Cell Biol. 130, 149–156.
Elk phosphorylation assay kinase buffer (25 mM Tris, 5 mM -glycer-
Fitzsimonds, R.M., and Poo, M.-M. (1998). Retrograde signaling inolphosphate, 2 mM DTT, 100 M sodium orthovanadate, 10 mM
the development of modification of synapses. Physiol. Rev. 78,MgCl2, 200 M ATP [pH 7.5]) at 4C. Then 25 l of 4C kinase buffer,
143–170.containing 2 g of recombinant Elk-GST fusion protein, was added
Gilad, G.M., and Gilad, V.H. (1986). Cytotoxic effects of monodansyl-to each sample prior to warming to 37C for 30 min in a water bath.
cadaverine and methylamine in primary cultures of rat cerebellarThe kinase reaction was terminated by adding 50 l of 7 M urea
neurons. Int. J. Devl. Neurosci. 4, 401–405.sample buffer and boiling.
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Topp, K., LaVail, J., Bunnett, N., and Mobley, W.C. (1996). Endocyto-Statistical Analysis
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